🔎 Trials Near Me

Beranda › Penyakit Autoimun › Distrik Columbia › Washington

Uji klinis Penyakit Autoimun di Washington, DC

19 studi untuk Penyakit Autoimun mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Menerima pesertaFase 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT03816345

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00867269

Natural History of Bronchiectasis

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 5 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00943514

NIAID Centralized Sequencing Protocol

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Children's National Health System, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
1 Day – 100 Years · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03206099

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Menerima pesertaFase 2Sukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 4 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT02579967

Environmental Risk Factors for the Anti-synthetase Syndrome

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01276470

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Menerima pesertaFase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 4 hingga 69 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04339777

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Menerima pesertaFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04097561

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

Menerima pesertaStudi observasional
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
1 Month – 100 Years · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT00246857

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Menerima pesertaStudi observasional
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Hingga usia 99 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT00001350

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Menerima pesertaFase 2
  • National Naval Medical Center, Bethesda · 7 mi jauhnya
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00977977

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Menerima pesertaFase 3
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
  • American Oncology Partners of Maryland, PA, Bethesda · 7 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Menerima pesertaFase 2/3
  • National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda · 7 mi jauhnya
Usia 6 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06154252

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Menerima pesertaFase 3
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06948318

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Menerima pesertaFase 3
  • Site Number - 1024, Washington D.C.
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07039916

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Menerima pesertaFase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05027945

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Menerima pesertaStudi observasional
  • Children's National Medical Center, Washington D.C.
  • Nih/Niaid, Bethesda · 7 mi jauhnya
  • Nih/Nhlbi, Bethesda · 7 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Menerima pesertaFase 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Usia 3 hingga 99 · Semua jenis kelamin · Diperbarui 9 Mar 2026 · NCT04304820

X-linked Moesin Associated Immunodeficiency

Menerima pesertaStudi observasional
  • National Institutes of Health, Bethesda · 7 mi jauhnya
Usia 4 hingga 80 · Pria · Diperbarui 25 Apr 2025 · NCT06278337

Uji klinis Penyakit Autoimun di kota lain

Studi lain di Washington

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.